vx 497 has been researched along with 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose in 1 studies
| Studies (vx 497) | Trials (vx 497) | Recent Studies (post-2010) (vx 497) | Studies (1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose) | Trials (1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose) | Recent Studies (post-2010) (1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose) |
|---|---|---|---|---|---|
| 25 | 3 | 7 | 235 | 1 | 138 |
| Protein | Taxonomy | vx 497 (IC50) | 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose (IC50) |
|---|---|---|---|
| Genome polyprotein | 1.6 | ||
| Prothrombin | Bos taurus (cattle) | 0.08 | |
| Coagulation factor X | Homo sapiens (human) | 0.17 | |
| Genome polyprotein | Coxsackievirus B3 (strain Nancy) | 1.1 | |
| Alpha-amylase 1A | Homo sapiens (human) | 2.35 | |
| Squalene monooxygenase | Rattus norvegicus (Norway rat) | 0.47 | |
| Ectonucleoside triphosphate diphosphohydrolase 1 | Mus musculus (house mouse) | 1.56 | |
| Beta-secretase 1 | Homo sapiens (human) | 3.76 | |
| Anthrax toxin receptor 2 | Homo sapiens (human) | 0.4535 | |
| Xanthine dehydrogenase/oxidase | Bos taurus (cattle) | 3.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 other study(ies) available for vx 497 and 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |